Grimes & Company’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.1M Buy
365,229
+57,131
+19% +$4.58M 0.65% 34
2026
Q1
$23.3M Buy
308,098
+57,454
+23% +$4.49M 0.65% 29
2025
Q4
$18.8M Buy
250,644
+61,234
+32% +$4.57M 0.45% 42
2025
Q3
$13.9M Buy
189,410
+54,406
+40% +$3.9M 0.34% 59
2025
Q2
$9.55M Buy
135,004
+37,136
+38% +$2.48M 0.26% 78
2025
Q1
$6.24M Buy
97,868
+49,833
+104% +$3.12M 0.19% 98
2024
Q4
$2.81M Buy
48,035
+43,608
+985% +$2.72M 0.08% 129
2024
Q3
$292K Buy
+4,427
New +$284K 0.01% 295

Other funds holding JIRE

Grimes & Company's JIRE Position: Q2 2026 in Review

Grimes & Company increased its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 19% in Q2 2026, buying an estimated $4.58M and bringing the position to 365,229 shares worth $30.1M. The position accounts for 0.65% of the portfolio, ranked #34.

Grimes & Company first reported a position in JIRE in Q3 2024 and has held it in 8 quarters since. 350 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Grimes & Company held 365,229 shares of JPMorgan International Research Enhanced Equity ETF worth $30.1M as of Q2 2026.
  • Grimes & Company bought 57,131 JPMorgan International Research Enhanced Equity ETF shares in Q2 2026, an estimated $4.58M.
  • JPMorgan International Research Enhanced Equity ETF made up 0.65% of Grimes & Company's portfolio in Q2 2026, its #34 holding.
  • Grimes & Company first reported a position in JPMorgan International Research Enhanced Equity ETF in Q3 2024 and has held it in 8 quarters since.
  • 350 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.